The genetic landscape of basal ganglia and implications for common brain disorders.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
01 Oct 2024
Historique:
received: 22 08 2023
accepted: 13 09 2024
medline: 2 10 2024
pubmed: 2 10 2024
entrez: 1 10 2024
Statut: epublish

Résumé

The basal ganglia are subcortical brain structures involved in motor control, cognition, and emotion regulation. We conducted univariate and multivariate genome-wide association analyses (GWAS) to explore the genetic architecture of basal ganglia volumes using brain scans obtained from 34,794 Europeans with replication in 4,808 white and generalization in 5,220 non-white Europeans. Our multivariate GWAS identified 72 genetic loci associated with basal ganglia volumes with a replication rate of 55.6% at P < 0.05 and 87.5% showed the same direction, revealing a distributed genetic architecture across basal ganglia structures. Of these, 50 loci were novel, including exonic regions of APOE, NBR1 and HLAA. We examined the genetic overlap between basal ganglia volumes and several neurological and psychiatric disorders. The strongest genetic overlap was between basal ganglia and Parkinson's disease, as supported by robust LD-score regression-based genetic correlations. Mendelian randomization indicated genetic liability to larger striatal volume as potentially causal for Parkinson's disease, in addition to a suggestive causal effect of greater genetic liability to Alzheimer's disease on smaller accumbens. Functional analyses implicated neurogenesis, neuron differentiation and development in basal ganglia volumes. These results enhance our understanding of the genetic architecture and molecular associations of basal ganglia structure and their role in brain disorders.

Identifiants

pubmed: 39353893
doi: 10.1038/s41467-024-52583-0
pii: 10.1038/s41467-024-52583-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8476

Informations de copyright

© 2024. The Author(s).

Références

Alexander, G. E. & Crutcher, M. D. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 13, 266–271 (1990).
pubmed: 1695401 doi: 10.1016/0166-2236(90)90107-L
Parent, A. Extrinsic connections of the basal ganglia. Trends Neurosci. 13, 254–258 (1990).
pubmed: 1695399 doi: 10.1016/0166-2236(90)90105-J
Haber, S. N. & Knutson, B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology 35, 4–26 (2010).
pubmed: 19812543 doi: 10.1038/npp.2009.129
Nelson, A. B. & Kreitzer, A. C. Reassessing models of basal ganglia function and dysfunction. Annu. Rev. Neurosci. 37, 117–135 (2014).
pubmed: 25032493 pmcid: 4416475 doi: 10.1146/annurev-neuro-071013-013916
DeLong, M. R. & Wichmann, T. Circuits and circuit disorders of the basal ganglia. Arch. Neurol. 64, 20–24 (2007).
pubmed: 17210805 doi: 10.1001/archneur.64.1.20
Grahn, J. A., Parkinson, J. A. & Owen, A. M. The cognitive functions of the caudate nucleus. Prog. Neurobiol. 86, 141–155 (2008).
pubmed: 18824075 doi: 10.1016/j.pneurobio.2008.09.004
Delmonte, S., Gallagher, L., O’hanlon, E., McGrath, J. & Balsters, J. H. Functional and structural connectivity of frontostriatal circuitry in Autism Spectrum Disorder. Front. Hum. Neurosci. 7, 430 (2013).
pubmed: 23964221 pmcid: 3734372 doi: 10.3389/fnhum.2013.00430
Redgrave, P. et al. Goal-directed and habitual control in the basal ganglia: implications for Parkinson’s disease. Nat. Rev. Neurosci. 11, 760–772 (2010).
pubmed: 20944662 pmcid: 3124757 doi: 10.1038/nrn2915
Yin, H. H. & Knowlton, B. J. The role of the basal ganglia in habit formation. Nat. Rev. Neurosci. 7, 464–476 (2006).
pubmed: 16715055 doi: 10.1038/nrn1919
Graybiel, A. M. Habits, rituals, and the evaluative brain. Annu. Rev. Neurosci. 31, 359–387 (2008).
pubmed: 18558860 doi: 10.1146/annurev.neuro.29.051605.112851
Frank, M. J. Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and nonmedicated Parkinsonism. J. Cogn. Neurosci. 17, 51–72 (2005).
pubmed: 15701239 doi: 10.1162/0898929052880093
D’Cruz, A.-M. et al. Reduced behavioral flexibility in autism spectrum disorders. Neuropsychology 27, 152 (2013).
pubmed: 23527643 pmcid: 3740947 doi: 10.1037/a0031721
McAlonan, G. M. et al. Brain anatomy and sensorimotor gating in Asperger’s syndrome. Brain: J. Neurol. 125, 1594–1606 (2002).
doi: 10.1093/brain/awf150
O’doherty, J. P. Reward representations and reward-related learning in the human brain: insights from neuroimaging. Curr. Opin. Neurobiol. 14, 769–776 (2004).
pubmed: 15582382 doi: 10.1016/j.conb.2004.10.016
Schultz, W. Behavioral theories and the neurophysiology of reward. Annu. Rev. Psychol. 57, 87–115 (2006).
pubmed: 16318590 doi: 10.1146/annurev.psych.56.091103.070229
Haber, S. N. Corticostriatal circuitry. Dialogues Clin. Neurosci. 18 (2022).
Cogswell, P. M. et al. Associations of quantitative susceptibility mapping with Alzheimer’s disease clinical and imaging markers. Neuroimage 224, 117433 (2021).
pubmed: 33035667 doi: 10.1016/j.neuroimage.2020.117433
Mostofsky, S. H. & Ewen, J. B. Altered connectivity and action model formation in autism is autism. Neuroscientist 17, 437–448 (2011).
pubmed: 21467306 pmcid: 3974163 doi: 10.1177/1073858410392381
Langen, M. et al. Changes in the development of striatum are involved in repetitive behavior in autism. Biol. psychiatry 76, 405–411 (2014).
pubmed: 24090791 doi: 10.1016/j.biopsych.2013.08.013
Mostofsky, S. H. & Simmonds, D. J. Response inhibition and response selection: two sides of the same coin. J. Cogn. Neurosci. 20, 751–761 (2008).
pubmed: 18201122 doi: 10.1162/jocn.2008.20500
Castellanos, F. X., Sonuga-Barke, E. J., Milham, M. P. & Tannock, R. Characterizing cognition in ADHD: beyond executive dysfunction. Trends Cogn. Sci. 10, 117–123 (2006).
pubmed: 16460990 doi: 10.1016/j.tics.2006.01.011
Luman, M., Tripp, G. & Scheres, A. Identifying the neurobiology of altered reinforcement sensitivity in ADHD: a review and research agenda. Neurosci. Biobehav. Rev. 34, 744–754 (2010).
pubmed: 19944715 doi: 10.1016/j.neubiorev.2009.11.021
Volkow, N. D. et al. Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway. Mol. Psychiatry 16, 1147–1154 (2011).
pubmed: 20856250 doi: 10.1038/mp.2010.97
Plichta, M. M. et al. Neural hyporesponsiveness and hyperresponsiveness during immediate and delayed reward processing in adult attention-deficit/hyperactivity disorder. Biol. Psychiatry 65, 7–14 (2009).
pubmed: 18718573 doi: 10.1016/j.biopsych.2008.07.008
Cubillo, A., Halari, R., Smith, A., Taylor, E. & Rubia, K. A review of fronto-striatal and fronto-cortical brain abnormalities in children and adults with Attention Deficit Hyperactivity Disorder (ADHD) and new evidence for dysfunction in adults with ADHD during motivation and attention. Cortex 48, 194–215 (2012).
pubmed: 21575934 doi: 10.1016/j.cortex.2011.04.007
Nigg, J. T. Neuropsychologic theory and findings in attention-deficit/hyperactivity disorder: the state of the field and salient challenges for the coming decade. Biol. Psychiatry 57, 1424–1435 (2005).
pubmed: 15950017 doi: 10.1016/j.biopsych.2004.11.011
Sonuga-Barke, E. J. & Fairchild, G. Neuroeconomics of attention-deficit/hyperactivity disorder: differential influences of medial, dorsal, and ventral prefrontal brain networks on suboptimal decision making? Biol. Psychiatry 72, 126–133 (2012).
pubmed: 22560046 doi: 10.1016/j.biopsych.2012.04.004
Solanto, M. V. Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research. Behav. Brain Res. 130, 65–71 (2002).
pubmed: 11864719 doi: 10.1016/S0166-4328(01)00431-4
Swanson, J. M. et al. Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychol. Rev. 17, 39–59 (2007).
pubmed: 17318414 doi: 10.1007/s11065-007-9019-9
Castellanos, F. X. & Tannock, R. Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat. Rev. Neurosci. 3, 617–628 (2002).
pubmed: 12154363 doi: 10.1038/nrn896
Howes, O. D. & Kapur, S. The dopamine hypothesis of schizophrenia: version III—the final common pathway. Schizophr. Bull. 35, 549–562 (2009).
pubmed: 19325164 pmcid: 2669582 doi: 10.1093/schbul/sbp006
Abi-Dargham, A. & Moore, H. Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia. Neuroscientist 9, 404–416 (2003).
pubmed: 14580124 doi: 10.1177/1073858403252674
Fornito, A., Yoon, J., Zalesky, A., Bullmore, E. T. & Carter, C. S. General and specific functional connectivity disturbances in first-episode schizophrenia during cognitive control performance. Biol. Psychiatry 70, 64–72 (2011).
pubmed: 21514570 pmcid: 4015465 doi: 10.1016/j.biopsych.2011.02.019
Andreasen, N. C. et al. Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia. Biol. Psychiatry 70, 672–679 (2011).
pubmed: 21784414 pmcid: 3496792 doi: 10.1016/j.biopsych.2011.05.017
Russo, S. J. & Nestler, E. J. The brain reward circuitry in mood disorders. Nat. Rev. Neurosci. 14, 609–625 (2013).
pubmed: 23942470 doi: 10.1038/nrn3381
Phillips, M. L., Ladouceur, C. D. & Drevets, W. C. A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Mol. Psychiatry 13, 833–857 (2008).
doi: 10.1038/mp.2008.65
Pizzagalli, D. A. Depression, stress, and anhedonia: toward a synthesis and integrated model. Annu. Rev. Clin. Psychol. 10, 393–423 (2014).
pubmed: 24471371 pmcid: 3972338 doi: 10.1146/annurev-clinpsy-050212-185606
Magon, S. et al. Morphological abnormalities of thalamic subnuclei in migraine: a multicenter MRI study at 3 tesla. J. Neurosci. 35, 13800–13806 (2015).
pubmed: 26446230 pmcid: 6605376 doi: 10.1523/JNEUROSCI.2154-15.2015
Lewis, M. M. et al. The pattern of gray matter atrophy in Parkinson’s disease differs in cortical and subcortical regions. J. Neurol. 263, 68–75 (2016).
pubmed: 26486354 pmcid: 4838560 doi: 10.1007/s00415-015-7929-7
Beyer, J. L. et al. Caudate volume measurement in older adults with bipolar disorder. Int. J. Geriatr. Psychiatry 19, 109–114 (2004).
pubmed: 14758576 doi: 10.1002/gps.1030
Ellison-Wright, I., Ellison-Wright, Z. & Bullmore, E. Structural brain change in attention deficit hyperactivity disorder identified by meta-analysis. BMC Psychiatry 8, 1–8 (2008).
doi: 10.1186/1471-244X-8-51
Nakao, T., Radua, J., Rubia, K. & Mataix-Cols, D. Gray matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication. Am. J. Psychiatry 168, 1154–1163 (2011).
pubmed: 21865529 doi: 10.1176/appi.ajp.2011.11020281
Kim, J. et al. Regional grey matter changes in patients with migraine: a voxel-based morphometry study. Cephalalgia 28, 598–604 (2008).
pubmed: 18422725 doi: 10.1111/j.1468-2982.2008.01550.x
Rojas, D. C. et al. Hippocampus and amygdala volumes in parents of children with autistic disorder. Am. J. Psychiatry 161, 2038–2044 (2004).
pubmed: 15514404 doi: 10.1176/appi.ajp.161.11.2038
Strakowski, S. M. et al. Ventricular and periventricular structural volumes in first-versus multiple-episode bipolar disorder. Am. J. Psychiatry 159, 1841–1847 (2002).
pubmed: 12411217 doi: 10.1176/appi.ajp.159.11.1841
DelBello, M. P., Zimmerman, M. E., Mills, N. P., Getz, G. E. & Strakowski, S. M. Magnetic resonance imaging analysis of amygdala and other subcortical brain regions in adolescents with bipolar disorder. Bipolar Disord. 6, 43–52 (2004).
pubmed: 14996140 doi: 10.1046/j.1399-5618.2003.00087.x
Wilke, M., Kowatch, R. A., DelBello, M. P., Mills, N. P. & Holland, S. K. Voxel-based morphometry in adolescents with bipolar disorder: first results. Psychiatry Res.: Neuroimaging 131, 57–69 (2004).
doi: 10.1016/j.pscychresns.2004.01.004
Estes, A. et al. Basal ganglia morphometry and repetitive behavior in young children with autism spectrum disorder. Autism Res. 4, 212–220 (2011).
pubmed: 21480545 pmcid: 3110551 doi: 10.1002/aur.193
Sears, L. L. et al. An MRI study of the basal ganglia in autism. Prog. Neuropsychopharmacol. Biol. Psychiatry 23, 613–624 (1999).
Hibar, D. P. et al. Common genetic variants influence human subcortical brain structures. Nature 520, 224–229 (2015).
pubmed: 25607358 pmcid: 4393366 doi: 10.1038/nature14101
Satizabal, C. L. et al. Genetic architecture of subcortical brain structures in 38,851 individuals. Nat. Genet. 51, 1624–1636 (2019).
pubmed: 31636452 pmcid: 7055269 doi: 10.1038/s41588-019-0511-y
van der Meer, D. et al. Making the MOSTest of imaging genetics. Biol. Psychiatry 87, S304–S305 (2020).
doi: 10.1016/j.biopsych.2020.02.784
van der Meer, D. et al. Understanding the genetic determinants of the brain with MOSTest. Nat. Commun. 11, 1–9 (2020).
Watanabe, K., Taskesen, E., Van Bochoven, A. & Posthuma, D. Functional mapping and annotation of genetic associations with FUMA. Nat. Commun. 8, 1–11 (2017).
doi: 10.1038/s41467-017-01261-5
Boyle, A. P. et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 22, 1790–1797 (2012).
pubmed: 22955989 pmcid: 3431494 doi: 10.1101/gr.137323.112
Kundaje, A. et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317–330 (2015).
pubmed: 25693563 pmcid: 4530010 doi: 10.1038/nature14248
Kircher, M. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46, 310–315 (2014).
pubmed: 24487276 pmcid: 3992975 doi: 10.1038/ng.2892
Smeland, O. B. et al. Genome-wide association analysis of Parkinson’s disease and schizophrenia reveals shared genetic architecture and identifies novel risk loci. Biol. Psychiatry 89, 227–235 (2021).
pubmed: 32201043 doi: 10.1016/j.biopsych.2020.01.026
Pickrell, J. K. et al. Detection and interpretation of shared genetic influences on 42 human traits. Nat. Genet. 48, 709–717 (2016).
pubmed: 27182965 pmcid: 5207801 doi: 10.1038/ng.3570
Leonenko, G. et al. Identifying individuals with high risk of Alzheimer’s disease using polygenic risk scores. Nat. Commun. 12, 4506 (2021).
pubmed: 34301930 pmcid: 8302739 doi: 10.1038/s41467-021-24082-z
Kulminski, A. M. et al. Genetic and regulatory architecture of Alzheimer’s disease in the APOE region. Alzheimer’s Dement. (Amst., Neth.) 12, e12008 (2020).
de Leeuw, C. A., Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput. Biol. 11, e1004219 (2015).
pubmed: 25885710 pmcid: 4401657 doi: 10.1371/journal.pcbi.1004219
Smeland, O. B., Frei, O., Dale, A. M. & Andreassen, O. A. The polygenic architecture of schizophrenia—rethinking pathogenesis and nosology. Nat. Rev. Neurol. 16, 366–379 (2020).
pubmed: 32528109 doi: 10.1038/s41582-020-0364-0
Andreassen, O. A., Hindley, G. F. L., Frei, O. & Smeland, O. B. New insights from the last decade of research in psychiatric genetics: discoveries, challenges and clinical implications. World Psychiatry 22, 4–24 (2023).
pubmed: 36640404 pmcid: 9840515 doi: 10.1002/wps.21034
Smeland, O. B. et al. Discovery of shared genomic loci using the conditional false discovery rate approach. Hum. Genet. 139, 85–94 (2020).
pubmed: 31520123 doi: 10.1007/s00439-019-02060-2
Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203–209 (2018).
pubmed: 30305743 pmcid: 6786975 doi: 10.1038/s41586-018-0579-z
Littlejohns, T. J. et al. The UK Biobank imaging enhancement of 100,000 participants: rationale, data collection, management and future directions. Nat. Commun. 11, 2624 (2020).
pubmed: 32457287 pmcid: 7250878 doi: 10.1038/s41467-020-15948-9
Deans, M. R. et al. Control of neuronal morphology by the atypical cadherin Fat3. Neuron 71, 820–832 (2011).
pubmed: 21903076 pmcid: 3521586 doi: 10.1016/j.neuron.2011.06.026
Santama, N., Er, C. P., Ong, L.-L. & Yu, H. Distribution and functions of kinectin isoforms. J. Cell Sci. 117, 4537–4549 (2004).
pubmed: 15316074 doi: 10.1242/jcs.01326
Mu, W., Tochen, L., Bertsch, C., Singer, H. S. & Barañano, K. W. Intracranial calcifications and dystonia associated with a novel deletion of chromosome 8p11.2 encompassing SLC20A2 and THAP1. BMJ Case Rep. 12, e228782 (2019).
Hsu, S. C. et al. Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification. Neurogenetics 14, 11–22 (2013).
pubmed: 23334463 pmcid: 4023541 doi: 10.1007/s10048-012-0349-2
Taglia, I., Bonifati, V., Mignarri, A., Dotti, M. T. & Federico, A. Primary familial brain calcification: update on molecular genetics. Neurol. Sci. 36, 787–794 (2015).
pubmed: 25686613 doi: 10.1007/s10072-015-2110-8
He, L. et al. ZIP8, member of the solute-carrier-39 (SLC39) metal-transporter family: characterization of transporter properties. Mol. Pharmacol. 70, 171–180 (2006).
pubmed: 16638970 doi: 10.1124/mol.106.024521
Choi, E.-K., Nguyen, T.-T., Gupta, N., Iwase, S. & Seo, Y. A. Functional analysis of SLC39A8 mutations and their implications for manganese deficiency and mitochondrial disorders. Sci. Rep. 8, 3163 (2018).
pubmed: 29453449 pmcid: 5816659 doi: 10.1038/s41598-018-21464-0
Horning, K. J., Caito, S. W., Tipps, K. G., Bowman, A. B. & Aschner, M. Manganese is essential for neuronal health. Annu. Rev. Nutr. 35, 71–108 (2015).
pubmed: 25974698 pmcid: 6525788 doi: 10.1146/annurev-nutr-071714-034419
Kong, L. et al. The ubiquitin E3 ligase TRIM10 promotes STING aggregation and activation in the Golgi apparatus. Cell Rep. 42 (2023).
Tamouza, R., Krishnamoorthy, R. & Leboyer, M. Understanding the genetic contribution of the human leukocyte antigen system to common major psychiatric disorders in a world pandemic context. Brain, Behav., Immun. 91, 731–739 (2021).
pubmed: 33031918 doi: 10.1016/j.bbi.2020.09.033
Endres, D. et al. Immunological causes of obsessive-compulsive disorder: is it time for the concept of an “autoimmune OCD” subtype? Transl. Psychiatry 12, 5 (2022).
pubmed: 35013105 pmcid: 8744027 doi: 10.1038/s41398-021-01700-4
Jiang, Q. et al. ApoE promotes the proteolytic degradation of Aβ. Neuron 58, 681–693 (2008).
pubmed: 18549781 pmcid: 2493297 doi: 10.1016/j.neuron.2008.04.010
Odagiri, S. et al. Autophagic adapter protein NBR1 is localized in Lewy bodies and glial cytoplasmic inclusions and is involved in aggregate formation in α-synucleinopathy. Acta Neuropathol. 124, 173–186 (2012).
pubmed: 22484440 doi: 10.1007/s00401-012-0975-7
Lange, S. et al. The kinase domain of titin controls muscle gene expression and protein turnover. Science 308, 1599–1603 (2005).
pubmed: 15802564 doi: 10.1126/science.1110463
Smith, T. M. et al. Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res. 6, 1029–1049 (1996).
pubmed: 8938427 doi: 10.1101/gr.6.11.1029
van der Meer, D. et al. The genetic architecture of human cortical folding. Sci. Adv. 7, eabj9446 (2021).
pubmed: 34910505 pmcid: 8673767 doi: 10.1126/sciadv.abj9446
Trachtenberg, J. T. et al. Long-term in vivo imaging of experience-dependent synaptic plasticity in adult cortex. Nature 420, 788–794 (2002).
pubmed: 12490942 doi: 10.1038/nature01273
Kozorovitskiy, Y., Saunders, A., Johnson, C. A., Lowell, B. B. & Sabatini, B. L. Recurrent network activity drives striatal synaptogenesis. Nature 485, 646–650 (2012).
pubmed: 22660328 pmcid: 3367801 doi: 10.1038/nature11052
Nie, X. et al. Subregional structural alterations in hippocampus and nucleus accumbens correlate with the clinical impairment in patients with Alzheimer’s disease clinical spectrum: parallel combining volume and vertex-based approach. Front. Neurol. 8, 399 (2017).
pubmed: 28861033 pmcid: 5559429 doi: 10.3389/fneur.2017.00399
Carrascoza, F. & Silaghi-Dumitrescu, R. The dynamics of hemoglobin-haptoglobin complexes. Relevance for oxidative stress. J. Mol. Struct. 1250, 131703 (2022).
doi: 10.1016/j.molstruc.2021.131703
Hyde, C. L. et al. Identification of 15 genetic loci associated with risk of major depression in individuals of European descent. Nat. Genet. 48, 1031–1036 (2016).
pubmed: 27479909 pmcid: 5706769 doi: 10.1038/ng.3623
Yue, S. et al. Gene-gene interaction and new onset of major depressive disorder: Findings from a Chinese freshmen nested case-control study. J. Affect. Disord. 300, 505–510 (2022).
pubmed: 34990634 doi: 10.1016/j.jad.2021.12.138
Muench, C. et al. The major depressive disorder GWAS-supported variant rs10514299 in TMEM161B-MEF2C predicts putamen activation during reward processing in alcohol dependence. Transl. Psychiatry 8, 131 (2018).
pubmed: 30006604 pmcid: 6045574 doi: 10.1038/s41398-018-0184-9
Wang, L. et al. TMEM161B modulates radial glial scaffolding in neocortical development. Proc. Natl Acad. Sci. USA 120, e2209983120 (2023).
pubmed: 36669109 pmcid: 9942823 doi: 10.1073/pnas.2209983120
Fischl, B. et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33, 341–355 (2002).
pubmed: 11832223 doi: 10.1016/S0896-6273(02)00569-X
Grasby, K. L. et al. The genetic architecture of the human cerebral cortex. Science 367 (2020).
Bulik-Sullivan, B. K. et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).
pubmed: 25642630 pmcid: 4495769 doi: 10.1038/ng.3211
Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47, 1236 (2015).
pubmed: 26414676 pmcid: 4797329 doi: 10.1038/ng.3406
Loughnan, R. J. et al. Generalization of cortical MOSTest genome-wide associations within and across samples. Neuroimage 263, 119632 (2022).
pubmed: 36115590 doi: 10.1016/j.neuroimage.2022.119632
Ochoa, D. et al. The next-generation Open Targets Platform: reimagined, redesigned, rebuilt. Nucleic Acids Res. 51, D1353–d1359 (2023).
pubmed: 36399499 doi: 10.1093/nar/gkac1046
Consortium, G. O. The Gene Ontology resource: enriching a GOld mine. Nucleic Acids Res. 49, D325–d334 (2021).
doi: 10.1093/nar/gkaa1113
Herwig, R., Hardt, C., Lienhard, M. & Kamburov, A. Analyzing and interpreting genome data at the network level with ConsensusPathDB. Nat. Protoc. 11, 1889–1907 (2016).
pubmed: 27606777 doi: 10.1038/nprot.2016.117
Dai, Y. et al. WebCSEA: web-based cell-type-specific enrichment analysis of genes. Nucleic Acids Res. 50, W782–w790 (2022).
pubmed: 35610053 pmcid: 10359109 doi: 10.1093/nar/gkac392
Franz, M. et al. GeneMANIA update 2018. Nucleic Acids Res. 46, W60–w64 (2018).
pubmed: 29912392 pmcid: 6030815 doi: 10.1093/nar/gky311
Freshour, S. L. et al. Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts. Nucleic Acids Res. 49, D1144–d1151 (2021).
pubmed: 33237278 doi: 10.1093/nar/gkaa1084
Demontis, D. et al. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nat. Genet. 51, 63–75 (2019).
pubmed: 30478444 doi: 10.1038/s41588-018-0269-7
Grove, J. et al. Identification of common genetic risk variants for autism spectrum disorder. Nat. Genet. 51, 431–444 (2019).
pubmed: 30804558 pmcid: 6454898 doi: 10.1038/s41588-019-0344-8
Mullins, N. et al. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat. Genet. 53, 817–829 (2021).
pubmed: 34002096 pmcid: 8192451 doi: 10.1038/s41588-021-00857-4
Wray, N. R. et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat. Genet. 50, 668–681 (2018).
pubmed: 29700475 pmcid: 5934326 doi: 10.1038/s41588-018-0090-3
Pardiñas, A. F. et al. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nat. Genet. 50, 381–389 (2018).
pubmed: 29483656 pmcid: 5918692 doi: 10.1038/s41588-018-0059-2
Wightman, D. P. et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease. Nat. Genet. 53, 1276–1282 (2021).
pubmed: 34493870 pmcid: 10243600 doi: 10.1038/s41588-021-00921-z
Gormley, P. et al. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat. Genet. 48, 856–866 (2016).
pubmed: 27322543 pmcid: 5331903 doi: 10.1038/ng.3598
Nalls, M. A. et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease. Nat. Genet. 46, 989–993 (2014).
pubmed: 25064009 pmcid: 4146673 doi: 10.1038/ng.3043
Nalls, M. A. et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson’s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 18, 1091–1102 (2019).
pubmed: 31701892 pmcid: 8422160 doi: 10.1016/S1474-4422(19)30320-5
Andreassen, O. A. et al. Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. Am. J. Hum. Genet. 92, 197–209 (2013).
pubmed: 23375658 pmcid: 3567279 doi: 10.1016/j.ajhg.2013.01.001
Andreassen, O. A. et al. Improved detection of common variants associated with schizophrenia and bipolar disorder using pleiotropy-informed conditional false discovery rate. PLoS Genet. 9, e1003455 (2013).
pubmed: 23637625 pmcid: 3636100 doi: 10.1371/journal.pgen.1003455
Bowden, J., Davey Smith, G., Haycock, P. C. & Burgess, S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet. Epidemiol. 40, 304–314 (2016).
pubmed: 27061298 pmcid: 4849733 doi: 10.1002/gepi.21965
Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44, 512–525 (2015).
pubmed: 26050253 pmcid: 4469799 doi: 10.1093/ije/dyv080
Relton, C. L. & Davey Smith, G. Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease. Int. J. Epidemiol. 41, 161–176 (2012).
pubmed: 22422451 pmcid: 3304531 doi: 10.1093/ije/dyr233
Verbanck, M., Chen, C.-Y., Neale, B. & Do, R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet. 50, 693–698 (2018).
pubmed: 29686387 pmcid: 6083837 doi: 10.1038/s41588-018-0099-7
Hemani, G. et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife 7, e34408 (2018).
pubmed: 29846171 pmcid: 5976434 doi: 10.7554/eLife.34408

Auteurs

Shahram Bahrami (S)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway. shahram.bahrami@medisin.uio.no.
KG Jebsen Centre for Neurodevelopmental disorders, University of Oslo, Oslo, Norway. shahram.bahrami@medisin.uio.no.

Kaja Nordengen (K)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Neurology, Oslo University Hospital, Oslo, Norway.

Jaroslav Rokicki (J)

Centre of Research and Education in Forensic Psychiatry, Oslo University Hospital, Oslo, Norway.

Alexey A Shadrin (AA)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
KG Jebsen Centre for Neurodevelopmental disorders, University of Oslo, Oslo, Norway.

Zillur Rahman (Z)

KG Jebsen Centre for Neurodevelopmental disorders, University of Oslo, Oslo, Norway.

Olav B Smeland (OB)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Piotr P Jaholkowski (PP)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Nadine Parker (N)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Pravesh Parekh (P)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Kevin S O'Connell (KS)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Torbjørn Elvsåshagen (T)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Neurology, Oslo University Hospital, Oslo, Norway.
Department of Behavioral Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.

Mathias Toft (M)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Neurology, Oslo University Hospital, Oslo, Norway.

Srdjan Djurovic (S)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.

Anders M Dale (AM)

Multimodal Imaging Laboratory, University of California San Diego, La Jolla, CA, USA.
Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA.
Department of Neurosciences, University of California San Diego, La Jolla, CA, USA.
Department of Radiology, University of California, San Diego, La Jolla, CA, USA.

Lars T Westlye (LT)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Psychology, Faculty of Social Sciences, University of Oslo, Oslo, Norway.

Tobias Kaufmann (T)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Psychiatry and Psychotherapy, Tübingen Center for Mental Health, University of Tübingen, Tübingen, Germany.
German Center for Mental Health (DZPG), Tübingen, Germany.

Ole A Andreassen (OA)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway. ole.andreassen@medisin.uio.no.
KG Jebsen Centre for Neurodevelopmental disorders, University of Oslo, Oslo, Norway. ole.andreassen@medisin.uio.no.
Department of Psychiatry, Oslo University Hospital, Oslo, Norway. ole.andreassen@medisin.uio.no.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH